Spyre Therapeutics Inc (SYRE)

Sales/Maturities of Investments

$410.68M

TTM · Period ending: · USD

SYRE logo

SYRE Sales/Maturities of Investments

Latest reported$410.68M
SYRE TTM Sales/Maturities of Investments ($0.00 → $410.68M)
High-resolution chart · PNG

SYRE sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Spyre Therapeutics Inc Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period endingSales/Maturities of Investments (USD)
410,677,000
408,104,000
371,739,000
339,988,000
318,590,000
269,600,000
245,967,000
202,319,000
124,526,000
69,900,000
39,900,000
39,500,000
63,250,000
85,000,000
96,546,000
100,959,000
109,329,000
106,329,000
111,033,000
148,740,000
145,470,000
139,534,000
125,676,000
80,806,000
77,831,000
78,017,000
91,679,000
100,679,000
85,554,000
76,389,000
47,370,000
29,655,000
37,065,000
39,550,000
42,205,000
37,850,000
21,690,000
14,136,000
8,446,000
5,766,000
3,766,000
1,750,000
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.